Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Acta Myol ; 39(1): 36-39, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32607479

RESUMEN

Mutations of the main voltage-gated K channel members Kv1.1 are linked to several clinical conditions, such as periodic ataxia type 1, myokymia and seizure disorders. Due to their role in active magnesium reabsorption through the renal distal convoluted tubule segment, mutations in the KCNA1 gene encoding for Kv1.1 has been associated with hypomagnesemia with myokymia and tetanic crises. Here we describe a case of a young female patient who came to our attention for a history of muscular spasms, tetanic episodes and muscle weakness, initially misdiagnosed for fibromyalgia. After a genetic screening she was found to be carrier of the c.736A > G (p.Asn255Asp) mutation in KCNA1, previously described in a family with autosomal dominant hypomagnesemia with muscular spasms, myokymia and tetanic episodes. However, our patient has always presented normal serum and urinary magnesium values, whereas she was affected by hypocalcemia. Calcium supplementation gave only partial clinical benefit, with an improvement on tetanic episodes yet without a clinical remission of her spasms, whereas magnesium supplementation worsened her muscular symptomatology.


Asunto(s)
Calcio/administración & dosificación , Hipocalcemia , Canal de Potasio Kv.1.1/genética , Magnesio/sangre , Miocimia , Tetania , Adulto , Encéfalo/diagnóstico por imagen , Hormonas y Agentes Reguladores de Calcio/administración & dosificación , Diagnóstico Diferencial , Femenino , Humanos , Hipocalcemia/diagnóstico , Hipocalcemia/etiología , Hipocalcemia/terapia , Imagen por Resonancia Magnética/métodos , Mutación , Miocimia/diagnóstico , Miocimia/tratamiento farmacológico , Miocimia/genética , Miocimia/fisiopatología , Examen Neurológico/métodos , Tetania/diagnóstico , Tetania/tratamiento farmacológico , Tetania/genética , Tetania/fisiopatología
2.
Nat Genet ; 8(3): 303-7, 1994 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7874174

RESUMEN

Defects in the human Ca(2+)-sensing receptor gene have recently been shown to cause familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. We now demonstrate that a missense mutation (Glu128Ala) in this gene causes familial hypocalcaemia in affected members of one family. Xenopus oocytes expressing the mutant receptor exhibit a larger increase in inositol 1,4,5-triphosphate in response to Ca2+ than oocytes expressing the wild-type receptor. We conclude that this extracellular domain mutation increases the receptor's activity at low Ca2+ concentrations, causing hypocalcaemia in patients heterozygous for such a mutation.


Asunto(s)
Calcio/sangre , Genes Dominantes , Hipocalcemia/genética , Mutación Puntual , Receptores de Superficie Celular/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Análisis Mutacional de ADN , ADN Complementario/genética , Femenino , Heterocigoto , Homeostasis , Humanos , Inositol 1,4,5-Trifosfato/metabolismo , Escala de Lod , Masculino , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Oocitos , Linaje , Receptores Sensibles al Calcio , Proteínas Recombinantes de Fusión/metabolismo , Tetania/genética , Xenopus laevis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA